Search
for
Sort by
Research 871–900 of 1000+
- 564 Vertex and Occipital Intermediate and Terminal Hair Follicles from Androgenetic Alopecia Patients are Differentially Affected by Testosterone Ex Vivo
- Every TURP Is not Just BPH
- Serum Ferritin Levels amongst Individuals with Androgenetic Alopecia in Ile-Ife, Nigeria.
- Erbium YAG Laser in the Treatment of Androgenetic Alopecia
- Is finasteride intake associated with penile curvature/peyronie’s disease? Assessment of both the food and drug administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
- 333 Poor perifollicular vascularization is associated with nutrient insufficiency and a quiescent metabolic phenotype in intermediate hair follicles from patients with female pattern hair loss
- Sexual adverse events-related to dutasteride e finasteride: analysis of real-life data from Eudra-Vigilance database
- MTHFR C677T Polymorphism and Serum Homocysteine Level as Risk Factors of Coronary Heart Disease in Patients with Androgenetic Alopecia: A Case Control Study
- Efficacy of platelet rich plasma intradermal injections for androgenetic alopecia treatment in males: A Before and after study
- 257 Is EBF1 a negative regulator of WNT10A in the development of androgenetic alopecia?
- [Androgenetic alopecia].
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
- Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
- Gender Differences in the Regulation of Blood Pressure
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
- Finasteride in the treatment of men with androgenetic alopecia
- Control of hair growth and follicle size by VEGF-mediated angiogenesis
- A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain1
- Folliculin encoded by the <i>BHD</i> gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling
- Proteasome Inhibitors: An Expanding Army Attacking a Unique Target
- The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
- The Membrane-Anchored <i>BOTRYTIS-INDUCED KINASE1</i> Plays Distinct Roles in <i>Arabidopsis</i> Resistance to Necrotrophic and Biotrophic Pathogens
- Regeneration of fat cells from myofibroblasts during wound healing
- The Neurobiology of Sexual Function
- Acute Selenium Toxicity Associated With a Dietary Supplement
- Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society